Biomarker

Dementia: Medications, Blood Tests, and AI Early Detection Breakthroughs

by

Researchers are increasingly turning to AI-driven diagnostics and blood-based biomarkers to improve the early detection of dementia, a shift that could fundamentally change how clinicians approach neurodegenerative conditions. While current diagnostic processes often rely on late-stage clinical symptoms, new diagnostic tools aim to identify biological changes years before cognitive decline becomes apparent. According to the … Read more

Study Links Plasma Vitamin C Levels to Gray Matter and Brain Network Connectivity

by

Recent neuroimaging research suggests a measurable link between plasma Vitamin C levels and the structural integrity of the human brain, specifically concerning gray matter volume and the connectivity of the Default Mode Network (DMN). A study published in Frontiers in Nutritional Neuroscience indicates that higher concentrations of circulating ascorbate may correlate with enhanced neurological resilience, … Read more

Silent Inflammation: The Hidden Culprit Behind Chronic Disease and New Treatment Strategies

by

For decades, the medical community has focused its most intense efforts on the visible battles of the immune system: the swelling of an infected wound, the fever of a viral onslaught, or the acute pain of an injury. However, a more insidious enemy has been operating beneath the surface, undetected by the traditional symptoms of … Read more

Parkinson’s Disease Starts Years Before Diagnosis: Early Signs, Biomarkers, and Sleep Disorders

by

For decades, the medical community has viewed the diagnosis of Parkinson’s disease as a moment defined by the appearance of visible motor symptoms. By the time a patient experiences the characteristic tremors or rigidity, a significant loss of dopaminergic neurons has already occurred. However, new neuroscientific evidence is shifting this paradigm, revealing that the disease … Read more